Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up
✍ Scribed by Tina J. Hieken; John Cheregi; Miguel Farolan; Joan Kim; Josè M. Velasco
- Book ID
- 116215984
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 69 KB
- Volume
- 194
- Category
- Article
- ISSN
- 0002-9610
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Ductal carcinoma in situ (DCIS) represents 20% of newly diagnosed breast carcinoma cases. Historically, the incidence of axillary metastasis in DCIS has been small (1–2%) and its significance has been debated. It is widely known that serial sections of lymph nodes coupled
## BACKGROUND. Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controversial. Most data regarding outcomes have co